HIGH

Midodrine Hydrochloride Tablets Recall 8,892 Cartons Nationwide (2026)

Midodrine Hydrochloride Tablets, 5 mg, 50 tablets in 5 x 10 blister packs, distributed nationwide by Major Pharmaceuticals, are recalled. The packaging defect involves inadequately sealed blister packaging. Healthcare providers and patients should stop using the product immediately and contact The Harvard Drug Group LLC for guidance.

Quick Facts at a Glance

Recall Date
February 17, 2026
Hazard Level
HIGH
Brand
Midodrine Hydrochloride
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Defective container; inadequately sealed blister packaging.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact The Harvard Drug Group LLC or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Midodrine hydrochloride is a prescription medication used to treat orthostatic hypotension by increasing blood pressure. It is supplied in tablet form for oral administration.

Why This Is Dangerous

A defective blister packaging can compromise drug integrity and may lead to contamination or reduced potency if used.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

The recall affects 8,892 cartons nationwide. Healthcare providers and patients should stop using the product immediately and seek guidance from The Harvard Drug Group. No injuries or deaths are reported in the notice.

Practical Guidance

How to identify if yours is affected

  1. Check NDC 0904-6818-06 on the package
  2. Locate Lot N02640 on the blister or carton
  3. Verify Expiration Date 08/2027
  4. If all match, stop using the product and contact the Harvard Drug Group for guidance

Where to find product info

FDA recall page: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0383-2026

What timeline to expect

Recall notice indicates disposition by letter from the Harvard Drug Group; exact refund/replacement timelines are not specified.

If the manufacturer is unresponsive

  • Document all communications with healthcare providers and the Harvard Drug Group
  • File a complaint with the FDA if the company is unresponsive
  • Consult your state pharmacy board for additional guidance

How to prevent similar issues

  • Verify NDC, lot number, and expiration date before dispensing any medication
  • Inspect packaging integrity on receipt of Rx drugs
  • Only use medications from approved and licensed pharmacies
  • When in doubt, contact a healthcare professional before use

Documentation advice

Keep recall notice, packaging, lot numbers, and all correspondence with the provider and distributor for records

Product Details

Product: Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs)\nNDC: 0904-6818-06\nLot: N02640\nExp: 08/2027\nRecall quantity: 8,892 cartons\nSold/distributed: Nationwide US\nDistributor/packager: Major Pharmaceuticals, Indianapolis, IN 46268 USA\nRecall date: 2026-02-17\nStatus: ACTIVE\nClassification: Class II

Key Facts

  • 8,892 cartons recalled
  • Lot N02640
  • Exp 08/2027
  • NDC 0904-6818-06
  • Distributed nationwide in the US
  • Defective blister packaging

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot N02640
UPC Codes
0904-6817
0904-6818
0904-6819
+5 more
Affected States
ALL
Report Date
March 11, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more
Vehicles & Parts
HIGH

Chrysler Pacifica Radio Recall 2025 Over Rearview Camera Display Issue

Chrysler is recalling 2024-2025 Pacifica minivans after a radio installed during production could fail to display the rearview camera image. Dealers will replace the radio at no cost. Owner letters were mailed August 7, 2025. Contact Chrysler customer service at 800-853-1403 for details.

Chrysler
A rearview
Read more